Partner Issues Significantly Influence Women’s Sexual Activity In Later Years, UCSF Study Shows

As a woman gets older, physical problems are less likely to influence whether she is sexually active than her partner’s health or interest in sex, according to a new study by researchers at the University of California, San Francisco and Kaiser Permanente. The study also showed significant differences in the frequency of [...]

BIO Comments On White House Letter On Biosimilars

Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following statement regarding the letter sent yesterday from the Obama Administration to House Energy and Commerce Committee Chairman Henry Waxman regarding biosimilars: “The Biotechnology Industry Organization continues to support strongly the development of a pathway [...]

FDA Approves Generic Version Of Emergency Contraception Pills

FDA on Wednesday approved Watson Pharmaceuticals’ generic version of the emergency contraceptive Plan B, the Wall Street Journal reports. The generic drug will be available without a prescription to women ages 18 and older on Aug. 24, when Duramed Pharmaceuticals’ market exclusivity for Plan B expires (Kalish, Wall Street Journal, 6/25).

U.S. Marshals Seize Drug Products Manufactured By Caraco Pharmaceutical Laboratories Ltd. FDA Acts To Prevent Repeated Drug Quality Problems

U.S. Marshals, at the request of the Food and Drug Administration, today seized drug products manufactured by Caraco Pharmaceutical Laboratories Ltd. (Caraco), at the company’s Michigan facilities in Detroit, Farmington Hills, and Wixom. The seizure also includes ingredients held at these same facilities. “The FDA is committed to taking enforcement action against firms that do [...]

Supply Shortages Of Cerezyme And Fabrazyme - Priority Access Forpatients Most In Need Of Treatment Recommended

The European Medicines Agency’s (EMEA) Committee for Medicinal Products for Human Use (CHMP) has recommended that patients who are in greatest need of treatment are given priority access to Cerezyme (imiglucerase) and Fabrazyme (agalsidase beta) during the expected supply shortage of these two medicines over the next [...]

ThromboGenics’ Microplasmin Phase III Program Progressing According To Schedule

ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces that its lead product microplasmin, which is in Phase III trials for the treatment of vitreomacular adhesion, is progressing according to schedule. All protocol-specified, interim masked analyses by the independent [...]

Insmed Announces Results Of IPLEX(TM) Phase II Trial In Myotonic Muscular Dystrophy

Insmed Inc. (Nasdaq: INSM), a biopharmaceutical company, announced results from its exploratory U.S. Phase II clinical trial evaluating IPLEX(TM) (mecasermin rinfabate) in patients with myotonic muscular dystrophy (”MMD”). The randomized, double-blind, placebo-controlled Phase II trial conducted in 13 centers across the U.S. enrolled 69 patients with MMD, for a six-month period. As this was [...]

Sanofi Pasteur Responds To Nation’s Need For Hib Vaccine With Increased Supply

Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced that the company has been able to increase the supply of its Hib-containing vaccines to enable the return to a full series of vaccinations for U.S. children. Based on the increased supply, on July 1, the U.S.

International Collaboration By Scientists Culminates In Novel Ion Channels Database

An important resource consolidating understanding of the roles played by Ion channels in drug action is now available for scientists and students. The International Union of Basic and Clinical Pharmacology (IUPHAR) announce the publication of a new ion channels database, covering both the voltage-gated (VGIC) and ligand-gated (LGIC) ion channels.

Goal Of Good Quality Medicines Advanced By New USP Agreement With 9 ASEAN Countries

Furthering its mission to improve the quality of medicines worldwide, the U.S. Pharmacopeial (USP) Convention has signed a cooperative agreement with nine countries belonging to the Association of Southeast Asian Nations (ASEAN).